Skip to content
Search

Latest Stories

PDA Union joins NHS National Staff Side, amplifying pharmacists' voice in Agenda for Change

Staff Side membership allows the PDA Union to participate in the NHS National Joint Council
gettyimages

Staff Side membership allows the PDA to participate in the NHS National Joint Council, which oversees changes to Agenda for Change

The Pharmacists' Defence Association (PDA) has secured the right to negotiate and agree on proposed changes to the NHS Agenda for Change (AfC) terms and conditions for its members.


This milestone follows an agreement with other NHS trade unions, enabling the PDA Union to join the NHS Staff Side. As part of this group, the PDA can now actively participate in the NHS National Joint Council, which oversees changes to AfC.

Participation in the NHS Staff Side brings significant benefits for PDA members, especially those employed in the NHS under AfC.

In addition to providing the PDA the right to negotiate and agree proposed changes to AfC, it empowers the trade union to advocate for pharmacists at the highest levels in the NHS, participate fully in the NHS Social Partnership Forum, and collaborate with other unions on critical issues such as NHS pay.

It also gives PDA members the right to be represented at local trust level on matters handled by local staff sides.

The PDA highlighted that this membership ensures equal representation rights for more than 7,000 NHS-employed members similar to those achieved for Boots employees five years ago.

Additionally, it strengthens the position of local PDA representatives, allowing them to join local negotiating committees and be fully involved in discussions on issues, such as changes to on-call arrangements, often delegated to local trusts and other employers.

While NHS pay remains under the purview of the NHS Pay Review Body—except in Scotland, where pay is negotiated directly with the Scottish Government—staff side membership enhances the PDA's access to the Pay Review Body.

It also enables the union to coordinate its approach with others who share its analysis in the campaign to ensure higher than inflation increases for NHS employees.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less